
Fluid Pharma and Mikart Partnership: ODT microparticles improve acceptability in patients with Dysphagia
Sustained Release Orally Disintegrating Tablets (ODTs) Comprising Coated Microparticles to Improve Acceptability in Patients with Dysphagia

Sustained Release Orally Disintegrating Tablets (ODTs) Comprising Coated Microparticles to Improve Acceptability in Patients with Dysphagia

Nanopharma Solutions platform is based on physical vapor deposition (PVD) Technology and makes drug nanoparticles with no excipients or solvents. NanoPharma Solutions nanodrug particles can be used in pills, nasal sprays, creams/salves, inhalers, eye drops, or injectables

Formulating a Fixed Dose Combination (FDC) of Artesunate (AS) and Amodiaquine (AQ) as taste masked micropellets for oral administration to children under 5 years.

*** Live: Wednesday, November 11, 2020 | 8:30 AM EDT – 4:00 PM EDT *** 2020 Bio/Pharma Virtual Congress: Join Pharmaceutical Technology® and BioPharm International® for this online event that will explore the latest developments in formulation, manufacturing, and innovative drug dosage forms, as well as detailed discussions about crucial topics impacting the industry. ***On demand available after final airing until 11/11/2021

Published: November 11th 2020 | Updated: